These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21342375)

  • 21. Patently necessary: improving global access to essential medicines.
    CMAJ; 2003 Dec; 169(12):1257, 1259. PubMed ID: 14662658
    [No Abstract]   [Full Text] [Related]  

  • 22. Access to essential drugs in 11 Brazilian cities: a community-based evaluation and action method.
    Karnikowski MG; Nóbrega OT; Naves JO; Silver LD
    J Public Health Policy; 2004; 25(3-4):288-98. PubMed ID: 15683066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Globalization, global health, and access to healthcare.
    Collins T
    Int J Health Plann Manage; 2003; 18(2):97-104. PubMed ID: 12841150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary health care: from aspiration to achievement.
    Diallo I; Molouba R; Sarr LC
    World Health Forum; 1993; 14(4):349-55. PubMed ID: 8185783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 27. [Access to essential medicines in Africa: a global approach].
    Millot G
    Med Trop (Mars); 2006 Dec; 66(6):558-64. PubMed ID: 17286021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Essential medicines for women and children].
    Lie SO; Apeland BG
    Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2150. PubMed ID: 23076479
    [No Abstract]   [Full Text] [Related]  

  • 29. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving global access to medicines for non-communicable diseases.
    Beran D; Perrin C; Billo N; Yudkin JS
    Lancet Glob Health; 2014 Oct; 2(10):e561-2. PubMed ID: 25304626
    [No Abstract]   [Full Text] [Related]  

  • 31. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacist's contribution to the promotion of access and rational use of essential medicines in SUS.
    Melo DO; Castro LL
    Cien Saude Colet; 2017 Jan; 22(1):235-244. PubMed ID: 28076546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Availability of essential medicines in selected public, primary and secondary health care institutions of a rural Sri Lankan district: a spot survey.
    Rathish D; Premarathna I; Jayathilake T; Kandegedara C; Punchihewa K; Ananda L; Bandara T; Jayasumana C; Siribaddana S
    BMC Health Serv Res; 2017 Jan; 17(1):11. PubMed ID: 28056960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adherence to essential medicines in cities from three Brazilian states].
    Dal Pizzol Tda S; Trevisol DJ; Heineck I; Flores LM; Camargo AL; Köenig A; Torres IL; Kadri MC; Monreal MT; Melo AM; Ferreira MB
    Cad Saude Publica; 2010 Apr; 26(4):827-36. PubMed ID: 20512222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Students, scientists push for access to drugs in developing world.
    Silversides A
    CMAJ; 2007 Mar; 176(7):914-5. PubMed ID: 17389431
    [No Abstract]   [Full Text] [Related]  

  • 36. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Essential medicines and the selection process in management practices of pharmaceutical services in Brazilian states and municipalities].
    Magarinos-Torres R; Pepe VL; Oliveira MA; Osorio-de-Castro CG
    Cien Saude Colet; 2014 Sep; 19(9):3859-68. PubMed ID: 25184591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicines prices and Malaysia--untangling the medicines web.
    Hill S
    PLoS Med; 2007 Mar; 4(3):e149. PubMed ID: 17388686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.
    Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV
    Global Health; 2017 Aug; 13(1):53. PubMed ID: 28764738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication access: all connected, all affected.
    Chisholm MA
    Am J Health Syst Pharm; 2003 Mar; 60(6):549. PubMed ID: 12659055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.